News

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...
Sarepta, other biotech stocks tumble as FDA appoints new CBER director ...
“There’s always uncertainty,” Merken said. “This is uncertainty on steroids.” In this turbulent environment, biotech buyers are treading cautiously. They’re more afraid to misstep than to miss out, ...
The first shards of hu­man da­ta on in vi­vo CAR-T cell ther­a­py look promis­ing, based on re­cent sep­a­rate re­ports from two biotech com­pa­nies’ aca­d­e­m­ic-led stud­ies … ...
Anant Ambani, Director, Reliance Industries Limited, along with his wife Radhika Merchant, performed Ganga Puja at Har Ki Pauri in Uttarakhand's Haridwar on Sunday. Anant Ambani, son of ...
Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees. In the ...
Those investments were tallied during a recalibration of biotech venture funding, with venture firms coalescing around a smaller number of surer bets that often come in the form of $100 million-plus ...
Buckner was speaking last month at Life Science Innovation Northwest, Seattle’s marquee gathering of the biotech industry. Most years, the two-day conference sees scientists, investors and other ...
While pharma giants like AstraZeneca and Johnson & Johnson also played prominent roles, much of the momentum and risk was carried by smaller biotech players suddenly thrown onto the global stage. For ...